Deutsche Bank Ag\ Axonics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Axonics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 716,919 shares of AXNX stock, worth $50.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

716,919

Previous 721,259 0.6%

Holding current value

$50.9 Million

Previous $48.5 Million 3.0%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$67.3 - $69.67 $292,082 - $302,367	-4,340 Reduced 0.6%	716,919 $49.9 Million
Q2 2024 Aug 14, 2024	SELL	$66.47 - $69.65 $12 Million - $12.6 Million	-181,074 Reduced 20.07%	721,259 $48.5 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $44.2 Million - $54.1 Million	779,493 Added 634.56%	902,333 $62.2 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $1.6 Million - $2.06 Million	32,382 Added 35.8%	122,840 $7.64 Million
Q3 2023 Nov 09, 2023	SELL	$48.64 - $62.51 $2.37 Million - $3.05 Million	-48,747 Reduced 35.02%	90,458 $5.08 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $1.02 Million - $1.28 Million	-21,224 Reduced 13.23%	139,205 $7.03 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $1.6 Million - $2.05 Million	30,437 Added 23.41%	160,429 $8.75 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $750,932 - $965,772	12,608 Added 10.74%	129,992 $8.13 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $415,283 - $559,729	-7,165 Reduced 5.75%	117,384 $8.27 Million
Q2 2022 Aug 11, 2022	BUY	$39.5 - $64.42 $243,873 - $397,729	6,174 Added 5.22%	124,549 $7.06 Million
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $335,660 - $481,620	-7,674 Reduced 6.09%	118,375 $7.41 Million
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $850,920 - $1.25 Million	-17,015 Reduced 11.89%	126,049 $7.06 Million
Q3 2021 Nov 04, 2021	BUY	$59.21 - $78.66 $147,492 - $195,942	2,491 Added 1.77%	143,064 $9.31 Million
Q2 2021 Aug 11, 2021	BUY	$51.39 - $66.9 $2.07 Million - $2.7 Million	40,289 Added 40.17%	140,573 $8.91 Million
Q1 2021 May 13, 2021	BUY	$49.14 - $59.89 $3.29 Million - $4.01 Million	66,892 Added 200.32%	100,284 $6.01 Million
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $1.41 Million - $1.72 Million	-33,406 Reduced 50.01%	33,392 $1.67 Million
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $1.68 Million - $2.42 Million	47,486 Added 245.89%	66,798 $3.41 Million
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $250,383 - $435,302	10,929 Added 130.37%	19,312 $677,000
Q1 2020 May 14, 2020	BUY	$16.44 - $37.73 $14,039 - $32,221	854 Added 11.34%	8,383 $213,000
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $59,003 - $87,314	3,015 Added 66.79%	7,529 $208,000
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $203,838 - $321,128	-7,572 Reduced 62.65%	4,514 $120,000
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $61,923 - $136,839	3,340 Added 38.19%	12,086 $493,000
Q1 2019 May 15, 2019	SELL	$13.32 - $24.35 $4,355 - $7,962	-327 Reduced 3.6%	8,746 $208,000
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $119,763 - $149,069	9,073 New	9,073 $137,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account